紫杉醇联合顺铂同步放化疗治疗局部晚期非小细胞肺癌的临床疗效及安全性评价OA北大核心CSCDCSTPCD
Paclitaxel combined with cisplatin concurrent chemo-radiation for the treatment of locally advanced non-small cell lung cancer
目的：评价紫杉醇联合顺铂同步放化疗治疗局部晚期非小细胞肺癌的临床疗效及安全性。方法将63例局部晚期非小细胞肺癌患者随机分为试验组30例和对照组33例。对照组给予放疗，放疗总剂量为60 Gy，2.0 Gy・ d-1，每周放疗5次，共6周。试验组在对照组的基础上，第1， 4 周给予紫杉醇135 mg・ m-2和顺铂70 mg・ m-2静脉输注化疗2个周期。放疗疗程结束2周后，评价2组的临床疗效及不良反应发生率。结果试验组客观反应率（76.7％）显著高…查看全部>>
Objective To evaluate the clinical effects and safety of pa-clitaxel combined with cisplatin concurrent chemo -radiation in the treat-ment of locally advanced non -small cell lung cancer.Methods A total of 63 patients with locally advanced non -small cell lung cancer were re-cruited from January 2012 to June 2014 in our hospital .The involved 63 cases were randomly divided into experiment group (30 cases) and con-trol group (33 subjects).The patients in the …查看全部>>
王宝强;周陈华
丽水市人民医院 放疗科，浙江 丽水 323000丽水市人民医院 放疗科，浙江 丽水 323000
医药卫生
紫杉醇顺铂局部晚期非小细胞肺癌放疗预后
paclitaxelcisplatinlocally advanced non-small lung cancerradiationprognosis
《中国临床药理学杂志》 2015 (8)
603-605,3
浙江省丽水市科技局科学研究基金资助项目（20038409）
评论